Outcomes of robot-assisted laparoscopic extended pelvic lymph node dissection for prostate Cancer by Silvan Sigg, Fabienne Lehner, Etienne Xavier Keller, Karim Saba, Holger Moch, Tullio Sulser, Daniel Eberli, Ashkan Mortezavi

Get full text

Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study by Thomas P. Scherer, Karim Saba, Marian S. Wettstein, Ilaria Lucca, Ashkan Mortezavi, Sharon Waisbrod, Drahomir Aujesky, Regula Capaul, Raeto T. Strebel

Get full text

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort by Jan Chandra Engel, Thorgerdur Palsdottir, Donna Ankerst, Sebastiaan Remmers, Ashkan Mortezavi, Venkatesh Chellappa, Lars Egevad, Henrik Grönberg, Martin Eklund, Tobias Nordström

Get full text

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer by Bram De Laere, Alessio Crippa, Ashkan Mortezavi, Christophe Ghysel, Prabhakar Rajan, Martin Eklund, Alexander Wyatt, Luc Dirix, Piet Ost, Henrik Grönberg, Johan Lindberg, on behalf of the CORE and ProBio Investigators

Get full text

MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. by Lotta von Boehmer, Lukas Keller, Ashkan Mortezavi, Maurizio Provenzano, Giovanni Sais, Thomas Hermanns, Tullio Sulser, Achim A Jungbluth, Lloyd J Old, Glen Kristiansen, Maries van den Broek, Holger Moch, Alexander Knuth, Peter J Wild

Get full text

68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement by Daniela A. Ferraro, Andreas M. Hötker, Anton S. Becker, Iliana Mebert, Riccardo Laudicella, Anka Baltensperger, Niels J. Rupp, Jan H. Rueschoff, Julian Müller, Ashkan Mortezavi, Marcelo T. Sapienza, Daniel Eberli, Olivio F. Donati, Irene A. Burger

Get full text